SEC Freezes Assets Tied to False Regulatory Filing
The SEC has obtained a court order to freeze the profits of a trader who allegedly manipulated a technology stock through a false regulatory filing traced to a computer in Pakistan.
All Work
Chris Lange
Why Sarepta’s PDUFA Delay Is a Good Thing
Sarepta Therapeutics Inc. (NASDAQ: SRPT) shares saw a handy gain on Wednesday following an analyst upgrade from Janney Montgomery Scott.
Cellectar Wins Big on New Patent
Cellectar Biosciences watched its shares skyrocket on Wednesday morning following the announcement that it has obtained a patent that covers CLR 1603, a phospholipid ether-paclitaxel.
How Express Is Dragging Its Feet With Earnings and Guidance
Express reported disappointing fiscal first-quarter financial results before the markets opened on Wednesday.
5 Major Clinical Trial Results Coming Up
24/7 Wall St. has collected several big FDA decisions and imminent clinical trial results that should be coming up in the June quarter. We have added some color.
Cybersecurity Short Interest Takes a Step Back
The May 13 short interest data have been compared with the previous figures, and short interest moves for the selected cybersecurity stocks were mixed.
Social Media Short Interest Sees Increased Bets
The May 13 short interest data have been compared with the previous report, and short interest increased in most of these selected social media stocks.
Major Oil Has Short Sellers Running for Cover
The May 13 short interest data have been compared with the previous figures, and short interest for most of the selected oil stocks decreased.
Short Interest Rises in Major Semiconductors in May
The May 13 short interest data have been compared with the previous report. On the broad scope, short interest moves increased in these selected semiconductor stocks.
Short Sellers Grow More Selective on Major Biotechs
The May 13 short interest data have been compared with the previous report, and short interest moves were mixed in these selected biotech stocks.
Short Sellers Take Mixed Stance on Major Pharma
The May 13 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
What the HPE and CSC Deal Really Means
Hewlett Packard Enterprise reported fiscal second-quarter financial results after the markets closed on Tuesday. There is far larger news here than mere earnings
What to Expect From Tiffany Earnings
Tiffany is scheduled to report its fiscal first-quarter financial results before the markets open on Wednesday.
3 Analysts Raise Parsley Energy Targets After Stock Offering, Acquisition
Parsley Energy has upsized its secondary offering, and three analysts have hiked their price targets for the stock.
Spherix Soars on New Licensing Agreement
Spherix shares more than doubled right out of the gate in Tuesday's trading session, after the company said it entered into a new licensing agreement with RPX.
What to Expect From Hewlett Packard Enterprise Earnings
Hewlett Packard Enterprise is scheduled to report its fiscal second-quarter financial results after the markets close on Tuesday.
Seaspan Stumbles on Secondary Pricing
Seaspan watched its shares sink early on Tuesday following the announcement of the pricing for its secondary offering.
Investors Shrug Off AutoZone Earnings Miss
AutoZone released a mixed fiscal third-quarter earnings report before the markets opened on Tuesday.
Nant Health Announces Potential Pricing for IPO
Nant Health expects to price more than 6 million shares in the range of $12.50 to $15.50 for an initial public offering valued up to more than $115 million.
Why Best Buy Investors Are Unimpressed With Earnings Beat
Best Buy reported better-than-expected fiscal first-quarter financial results before the markets opened on Tuesday.